Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
63.7M
-
Shares change
-
+3.92M
-
Total reported value, excl. options
-
$533M
-
Value change
-
+$32.5M
-
Put/Call ratio
-
0.04
-
Number of buys
-
52
-
Number of sells
-
-74
-
Price
-
$8.37
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q2 2022
168 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q2 2022.
Gossamer Bio, Inc. - Common Stock (GOSS) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.7M shares
of 227M outstanding shares and own 28.02% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7.42M shares), VANGUARD GROUP INC (5.85M shares), BlackRock Inc. (5.17M shares), STATE STREET CORP (3.88M shares), FEDERATED HERMES, INC. (3.53M shares), Octagon Capital Advisors LP (2.76M shares), BOXER CAPITAL, LLC (2.46M shares), Artal Group S.A. (2.36M shares), Kynam Capital Management, LP (2.35M shares), and CITADEL ADVISORS LLC (2.28M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.